What is happening with the supply of oncology drugs in Brazil and the world?

Por de Souza, Carmino Antonio
Publicado em 2012

The evolution of drug therapy and the challenges to physicians, patients and healthcare systems

Por de Souza, Cármino Antonio
Publicado em 2011

The evolution of the "Revista Brasileira de Hematologia e Hemoterapia" to meet the challenges of a new era

Por de Souza, Cármino Antonio
Publicado em 2011

Five years of implementation of guidelines in hematology and transfusion medicine in Brazil

Por de Souza, Carmino Antonio
Publicado em 2014

Many thanks to our eternal Editor of the Revista Brasileira de Hematologia e Hemoterapia, Professor Milton Artur Ruiz

Por de Souza, Cármino Antonio
Publicado no Rev Bras Hematol Hemoter (2015)

Involvement of cranial nerves in a patient with secondary central nervous system lymphoma

Por Dantas Azevedo, Roberta, Reis, Fabiano, Torresan Delamain, Marcia, de Souza, Cármino Antônio
Publicado no Rev Bras Hematol Hemoter (2016)

Intracranial primary dural diffuse large B-cell lymphoma successfully treated with chemotherapy

Por Brito, Angelo Borsarelli Carvalho, Reis, Fabiano, de Souza, Cármino Antonio, Vassallo, José, Lima, Carmen Silvia Passos
Publicado em 2014

Importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or in...

Por Simões, Belinda Pinto, Braga Junior, José Wilson Ramos, Rego, Maria Aparecida do Carmo, de Souza, Cármino Antônio
Publicado em 2011

Evaluation of respiratory conditions in early phase of hematopoietic stem cell transplantation

Por Bom, Eliane Aparecida, de Souza, Clarissa Vasconcelos, Thiesen, Rosana Almeida da Silva, Miranda, Eliana Cristina Martins, de Souza, Carmino Antonio
Publicado em 2012

Treatment Outcome of Acute Promyelocytic Leukemia with Modified Aida Protocol

Por Pagnano, Kátia B. Barbosa, Duarte, Gustavo de Carvalho, Lorand-Metze, Irene, Delamain, Márcia Torresan, Miranda, Eliana Cristina, De Souza, Cármino Antonio
Publicado em 2010

Functional evaluation indicates physical losses after hematopoietic stem cell transplantation

Por de Souza, Clarissa Vasconcellos, Miranda, Eliana Cristina Martins, Garcia Jr, Celso, Aranha, Francisco José Penteado, de Souza, Cármino Antonio, Vigorito, Afonso Celso
Publicado em 2012

Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation

Por Franceschi, Danilo Santana Alessio, de Souza, Cármino Antonio, Aranha, Francisco José Penteado, Cardozo, Daniela Maira, Sell, Ana Maria, Visentainer, Jeane Eliete Laguila
Publicado em 2011

Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up

Por PAGNANO, KATIA BORGIA BARBOSA, DELAMAIN, MÁRCIA TORRESAN, MAGNUS, MARIANA MUNARI, VASSALLO, JOSÉ, DE SOUZA, CARMINO ANTONIO, DE ALMEIDA, DAIANE, LORAND-METZE, IRENE
Publicado no Oncol Lett (2016)

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial

Por Brümmendorf, Tim H, Cortes, Jorge E, de Souza, Cármino Antonio, Guilhot, Francois, Duvillié, Ladan, Pavlov, Dmitri, Gogat, Karïn, Countouriotis, Athena M, Gambacorti-Passerini, Carlo
Publicado no Br J Haematol (2015)

Philadelphia-negative chronic myeloproliferative neoplasms

Por Bittencourt, Rosane Isabel, Vassallo, Jose, Chauffaille, Maria de Lourdes Lopes Ferrari, Xavier, Sandra Guerra, Pagnano, Katia Borgia, Nascimento, Ana Clara Kneese, De Souza, Carmino Antonio, Chiattone, Carlos Sergio
Publicado em 2012

Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response

Por Machado, Melissa Pereira, Tomaz, Juarez Pires, Lorand-Metze, Irene, de Souza, Cármino Antonio, Vigorito, Afonso Celso, Delamain, Marcia Torresan, Bendit, Israel, Pereira, Noemi Farah, Pagnano, Katia Borgia Barbosa
Publicado em 2011

Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012

Por de Souza, Carmino Antonio, Pagnano, Katia Borgia Barbosa, Bendit, Israel, Conchon, Monika, Freitas, Carla Maria Boquimpani de Moura, Coelho, Arthur Moellmann, Funke, Vaneuza Araújo Moreira, Bernardo, Wanderley Marques
Publicado em 2012

Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia

Por Bizzetto, Renata, Bonfim, Carmen, Rocha, Vanderson, Socié, Gérard, Locatelli, Franco, Chan, KaWah, Ramirez, Oscar, Stein, Joel, Nabhan, Samir, Miranda, Eliana, Passweg, Jakob, de Souza, Carmino Antonio, Gluckman, Eliane
Publicado em 2011

Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome

Por Benites, Bruno Deltreggia, Lima, Carolina Silva Costa, Lorand-Metze, Irene, Delamain, Marcia Torresan, Oliveira, Gislaine Borba, de Almeida, Daiane, de Souza, Carmino Antonio, Vassallo, Jose, Pagnano, Katia Borgia Barbosa
Publicado em 2013

Comparison of Diagnostic Tests in Distinct Well-Defined Conditions Related to Dry Eye Disease

Por Alves, Monica, Reinach, Peter Sol, Paula, Jayter Silva, Vellasco e Cruz, Antonio Augusto, Bachette, Leticia, Faustino, Jacqueline, Aranha, Francisco Penteado, Vigorito, Afonso, de Souza, Carmino Antonio, Rocha, Eduardo Melani
Publicado em 2014